79 related articles for article (PubMed ID: 1478351)
21. Insect cells as a new substrate for vaccine production.
Dalemans W
Dev Biol (Basel); 2006; 123():235-41; discussion 265-6. PubMed ID: 16566449
[TBL] [Abstract][Full Text] [Related]
22. [Presence of Mycoplasma in laboratory cell cultures from Cordoba, Argentina].
Cumino AC; Córdoba P; Zapata TM
Rev Argent Microbiol; 1998; 30(3):147-53. PubMed ID: 9793145
[TBL] [Abstract][Full Text] [Related]
23. Internucleosomal DNA fragmentation in cultured cells under conditions reported to induce apoptosis may be caused by mycoplasma endonucleases.
Paddenberg R; Wulf S; Weber A; Heimann P; Beck LA; Mannherz HG
Eur J Cell Biol; 1996 Sep; 71(1):105-19. PubMed ID: 8884184
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility of various cell culture systems to bovine viral diarrhea virus.
Ferrari M
Microbiologica; 1985 Jan; 8(1):17-22. PubMed ID: 2983178
[TBL] [Abstract][Full Text] [Related]
25. Effect of substrata and fibroblast growth factor on the proliferation in vitro of bovine aortic endothelial cells.
Gospodarowicz D; Lui GM
J Cell Physiol; 1981 Oct; 109(1):69-81. PubMed ID: 6460040
[TBL] [Abstract][Full Text] [Related]
26. Spiroplasmas: infectious agents of plants, arthropods and vertebrates.
Bové JM
Wien Klin Wochenschr; 1997 Aug; 109(14-15):604-12. PubMed ID: 9286068
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility of the Sf9 insect cell line to infection with adventitious viruses.
Zhang PF; Klutch M; Muller J; Marcus-Sekura CJ
Biologicals; 1994 Sep; 22(3):205-13. PubMed ID: 7811453
[TBL] [Abstract][Full Text] [Related]
28. Effect of medium supplements on tick cells in culture.
Kurtti TJ; Munderloh UG; Samish M
J Parasitol; 1982 Oct; 68(5):930-5. PubMed ID: 7131199
[TBL] [Abstract][Full Text] [Related]
29. Strategy for adventitious agent assays.
Robertson JS
Dev Biol Stand; 1996; 88():37-40. PubMed ID: 9119160
[TBL] [Abstract][Full Text] [Related]
30. [Contamination of bovine fetal serum with bovine viral diarrhea virus].
Zabal O; Kobrak AL; Lager IA; Schudel AA; Weber EL
Rev Argent Microbiol; 2000; 32(1):27-32. PubMed ID: 10785940
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility of mouse minute virus to inactivation by heat in two cell culture media types.
Schleh M; Romanowski P; Bhebe P; Zhang L; Chinniah S; Lawrence B; Bashiri H; Gaduh A; Rajurs V; Rasmussen B; Chuck A; Dehghani H
Biotechnol Prog; 2009; 25(3):854-60. PubMed ID: 19405099
[TBL] [Abstract][Full Text] [Related]
32. Production of influenza virus in serum-free mammalian cell cultures.
Merten OW; Manuguerra JC; Hannoun C; van der Werf S
Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957
[TBL] [Abstract][Full Text] [Related]
33. Mycoplasmal contamination of cell cultures.
Lundin DJ
Am Biotechnol Lab; 1994 Jul; 12(8):42. PubMed ID: 7765012
[No Abstract] [Full Text] [Related]
34. Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products.
Khuu HM; Stock F; McGann M; Carter CS; Atkins JW; Murray PR; Read EJ
Cytotherapy; 2004; 6(3):183-95. PubMed ID: 15203975
[TBL] [Abstract][Full Text] [Related]
35. Methods for the detection of adventitious viruses in cell cultures used in the production of biotechnology products.
Poiley JA
Bioprocess Technol; 1990; 10():483-94. PubMed ID: 1367069
[TBL] [Abstract][Full Text] [Related]
36. Microbiological control in stem cell banks: approaches to standardisation.
Cobo F; Stacey GN; Hunt C; Cabrera C; Nieto A; Montes R; Cortés JL; Catalina P; Barnie A; Concha A
Appl Microbiol Biotechnol; 2005 Sep; 68(4):456-66. PubMed ID: 16012832
[TBL] [Abstract][Full Text] [Related]
37. Viral risk mitigation for Mammalian cell culture media.
Weaver B; Rosenthal S
PDA J Pharm Sci Technol; 2010; 64(5):436-9. PubMed ID: 21502048
[TBL] [Abstract][Full Text] [Related]
38. Best practices for detecting and mitigating the risk of cell culture contaminants.
Nims RW; Price PJ
In Vitro Cell Dev Biol Anim; 2017 Dec; 53(10):872-879. PubMed ID: 29197027
[TBL] [Abstract][Full Text] [Related]
39. Risk Mitigation in Preventing Adventitious Agent Contamination of Mammalian Cell Cultures.
Shiratori M; Kiss R
Adv Biochem Eng Biotechnol; 2018; 165():75-93. PubMed ID: 29134459
[TBL] [Abstract][Full Text] [Related]
40. From bench to cageside: Risk assessment for rodent pathogen contamination of cells and biologics.
Peterson NC
ILAR J; 2008; 49(3):310-5. PubMed ID: 18506064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]